CINECA IRIS Institutional Research Information System

PELLERINO, Alessia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.233
EU - Europa 1.228
AS - Asia 751
SA - Sud America 36
AF - Africa 19
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.205
IT - Italia 312
CN - Cina 289
SG - Singapore 224
IE - Irlanda 207
SE - Svezia 160
UA - Ucraina 148
DE - Germania 79
FR - Francia 74
FI - Finlandia 50
JP - Giappone 48
GB - Regno Unito 45
KR - Corea 44
ES - Italia 29
VN - Vietnam 29
AT - Austria 28
IN - India 27
BR - Brasile 22
ID - Indonesia 21
CA - Canada 20
BE - Belgio 19
AU - Australia 17
PL - Polonia 17
IR - Iran 15
NL - Olanda 14
IL - Israele 12
NG - Nigeria 10
TR - Turchia 10
HK - Hong Kong 7
MX - Messico 7
RS - Serbia 7
RU - Federazione Russa 7
UZ - Uzbekistan 7
CH - Svizzera 6
CZ - Repubblica Ceca 5
RO - Romania 5
AR - Argentina 4
BD - Bangladesh 4
BG - Bulgaria 4
CO - Colombia 4
DK - Danimarca 4
PK - Pakistan 4
TW - Taiwan 4
CL - Cile 3
MA - Marocco 3
SN - Senegal 3
AM - Armenia 2
HR - Croazia 2
NO - Norvegia 2
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HU - Ungheria 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
TG - Togo 1
TH - Thailandia 1
Totale 4.285
Salva come PNG Salva come JPEG
Città #
Chandler 414
Dublin 207
Singapore 177
Beijing 143
Nyköping 108
Fairfield 103
Ashburn 82
Houston 79
Medford 74
Princeton 61
Jacksonville 59
Ann Arbor 58
Woodbridge 58
Torino 50
Wilmington 49
Seattle 45
Cambridge 42
Dearborn 42
Redwood City 37
Santa Clara 37
New York 36
Turin 36
Villeurbanne 31
Vienna 28
Fremont 27
Jakarta 21
Boston 19
Boardman 17
Hangzhou 17
Milan 17
Pisa 16
Dong Ket 15
Guangzhou 14
Seoul 13
Florence 11
Tel Aviv 11
Warsaw 11
Brussels 10
Norwalk 10
London 9
Nanjing 9
Paris 9
Tokyo 9
Abuja 8
Bari 8
Kunming 7
Toronto 7
Washington 7
Amsterdam 6
Chengdu 6
Hefei 6
Imola 5
Los Angeles 5
Madrid 5
Novi Sad 5
Ottawa 5
Bucha 4
Curitiba 4
Dhaka 4
Genova 4
Helsinki 4
Istanbul 4
Krakow 4
Lyon 4
Marseille 4
Melbourne 4
Moncalieri 4
Orio Canavese 4
Rome 4
San Diego 4
San Mateo 4
Sofia 4
São Paulo 4
Aarhus 3
Bilthoven 3
Bogotá 3
Bologna 3
Brussel 3
Camerino 3
Chongqing 3
Costa Mesa 3
Edinburgh 3
Errenteria 3
Goiânia 3
Hebei 3
Heidelberg 3
Islamabad 3
Jinan 3
Madison 3
Marrakesh 3
Mexico City 3
Milazzo 3
Olomouc 3
Pars 3
Phoenix 3
Richmond 3
Rivoli 3
Sirignano 3
Tehran 3
Upper Marlboro 3
Totale 2.550
Salva come PNG Salva come JPEG
Nome #
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 291
TDP-43 Redistribution Is an Early Event in Sporadic Amyotrophic Lateral Sclerosis 275
Response to combined radiotherapy and chemotherapy of a leptomeningeal spread from choroid plexus carcinoma: case report. 251
Does valproic acid affect tumor growth and improve survival in glioblastomas? 147
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target 119
TP53 gene polymorphisms and mutations’ correlation in blood and tumoral tissue in a group of patients with gliomas 108
Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor 103
Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring 88
An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression 87
Progranulin plasma levels in relation to the expected TDP-43 pathology. 87
TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis 85
Molecularly based management of gliomas in clinical practice 85
Progranulin plasma levels in patients with and without TDP-43 pathology. 85
Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review. 81
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study 80
Antiangiogenic therapy of brain tumors: The role of bevacizumab 80
Epidemiology, risk factors, and prognostic factors of gliomas 79
Depatuxizumab mafodotin (Depatux-M) plus temozolomide (TMZ) in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO) 78
Current clinical management of elderly patients with glioma 76
Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes 75
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments 68
Genetic analysis of TDP-43 gene in blood and tumoral tissue in a group of patients with gliomas 67
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 65
Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. 63
Supratotal Resection of Glioblastoma: Is Less More? 62
NCOG-19. PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE INSTITUTIONAL SERIES OF 160 PATIENTS 61
Ependymoma: Evaluation and Management Updates 60
Neuropathology of Olfactory Ensheathing Cell Transplantation into the Brain of Two Amyotrophic Lateral Sclerosis (ALS) Patients. 59
Spinal melanocytoma with leptomeningeal spread and long survival following surgery and chemotherapy 59
Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults. 56
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups 54
The expression pattern of TDP43 protein ion periphearal leukocytes and spinal cord from ALS patients is consistent with impaired tran sport across the nuclear envelope 53
Depatuxizumab mafodotin (Depatux-m) plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of italian association of neuro-oncology (aino) 53
Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response 51
Epilepsy in brain metastasis: an emerging entity 49
Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances 47
Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling 46
Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors 45
Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects 45
Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma 45
Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors 44
Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival. A Single Institution Experience 44
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance 43
Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program 43
Long-term survival of a sacro-coccygeal myxopapillary ependymoma with extra-neural metastases: case report and review of the literature 42
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups 42
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? 42
Single-agent Bevacizumab in Recurrent Glioblastoma after Second-line Chemotherapy with Fotemustine the Experience of the Italian Association of Neuro-Oncology 38
Overview on current treatment standards in high-grade gliomas 36
Management of Brain and Leptomeningeal Metastases from Breast Cancer 36
Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature 36
Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study 33
Targeted therapies in rare brain tumours 31
Systemic Therapy for Lung Cancer Brain Metastases 31
Current and Future Drugs for Brain Tumors Treatment 30
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy? 28
Subependymal Giant Cell Astrocytomas (SEGAs): a Model of Targeting Tumor Growth and Epilepsy 28
Neuro-oncology perspective of treatment options in metastatic breast cancer 23
Natural history and spontaneous prognostic factors 22
Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee 21
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter? 21
Diagnosis and Treatment of Peripheral and Cranial Nerve Tumors with Expert Recommendations: An EUropean Network for RAre CANcers (EURACAN) Initiative 19
Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy 16
I tumori del sistema nervoso centrale e periferico 16
Strategies to prevent brain metastasis 16
Leptomeningeal metastases from solid tumors: Recent advances in diagnosis and molecular approaches 16
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study 15
Brain metastasis from HER2-positive breast cancer: an evolving landscape 15
Newly diagnosed glioblastoma: A review on clinical management 15
Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2-Mutant Lower-Grade Glioma 14
Epilepsy in gliomas: recent insights into risk factors and molecular pathways 14
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors 12
Primary Meningeal Melanocytic Tumors of the Central Nervous System: A Review from the Ultra-Rare Brain Tumors Task Force of the European Network for Rare Cancers (EURACAN) 11
The Impact of Lateral Ventricular Opening in the Resection of Newly Diagnosed High-Grade Gliomas: A Single Center Experience 11
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma 11
[18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas 10
The early recognition and diagnosis of neoplastic meningitis 8
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases 7
The role of the neurologist in the diagnosis and treatment of brain metastases and carcinomatous meningitis 7
Epilepsy in CNS Metastases 6
Prevention of Brain Metastases: A New Frontier 6
TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells 6
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419) 6
Brain Metastases 5
Neoplasie cerebrali 5
Prevention strategies for brain mestasases 4
Blood and cerebrospinal fluid biomarkers in neuro-oncology 3
The role of molecular factors and magnetic resonance spectroscopy in the management of diffuse lower-grade gliomas with or without epilepsy 2
Totale 4.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.370
article - articoli 0
book - libri 0
conference - conferenze 2.189
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020424 0 0 0 42 16 66 59 48 50 57 45 41
2020/2021459 44 41 23 34 62 44 24 33 31 39 33 51
2021/2022782 20 19 28 33 21 87 28 42 16 124 209 155
2022/20231.266 108 105 41 148 92 284 101 92 141 35 84 35
2023/2024470 59 97 32 25 19 55 12 38 2 32 33 66
2024/2025405 23 190 97 95 0 0 0 0 0 0 0 0
Totale 4.458